Jacobs Levy Equity Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $187M | Buy |
|
|||||
|
2025
Q2 | $5.76M | Sell |
|
|||||
|
2025
Q1 | $41.3M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.23M | Sell |
|
|||||
|
2024
Q1 | $18.9M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.25M | Sell |
|
|||||
|
2022
Q1 | $5.11M | Sell |
|
|||||
|
2021
Q4 | $11.5M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $259K | Sell |
|
|||||
|
2021
Q1 | $1.17M | Sell |
|
|||||
|
2020
Q4 | $1.17M | Buy |
|
|||||
|
2020
Q3 | $983K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $8.25M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $453K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.39M | Sell |
|
|||||
|
2016
Q1 | $10.3M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $472K | Sell |
|
|||||
|
2015
Q1 | $777K | Buy |
|